USTR review could mean tough times ahead
Withdrawal of the GSP scheme could hit the industry quite hard
Author
The most important thing is what the customer needs
Presenting Japanese technology at Indian cost is the main aim of the joint venture between Tokyo-based Freund Corporation and…
Will a toothless drug price watchdog be good or bad for business?
A quid pro quo, of an easing drug price control, in exchange for increased investments in manufacturing, backward integration…
Glatt does not just sell machines, we provide unique solutions to customers’ requirements
Mirko Nowak, Corporate Marketing, Glatt represents part of the third generation of the family-owned business started by his…
Out with the old, on with the new
Pfizer's loss will be the gain of numerous pharma companies and CROs as they look to hire from this talent pool
The new year…
A race to the bottom on price must not mean low quality, high volumes
Professor (Dr) Hilary Thomas, Partner and Chief Medical Officer - Healthcare and Life Sciences Advisory and Global Centre of…
India is a critically important market for Waters
India is the third largest pharma market for Waters, contributing a significant portion of the company's annual growth. On a…
Where is the patient in the e-pharmacy debate?
e-pharmacies cannot be considered a mere extension of the e-commerce boom, simply because the patient cannot tell the difference…
Automation Fair 2018 links people, machines, data into a connected future
Renewed commitment to its Connected Enterprise platform defined Rockwell Automation's 27th Automation Fair held in Philadelphia…